Union Health Minister unveils world’s first intranasal COVID-19 vaccine, Bharat Biotech’s iNNCOVACC

Union Health Minister Dr. Mansukh Mandaviya unveiled the world’s first intranasal COVID-19 vaccine, iNNCOVACC, in New Delhi on January 26, 2023. The vaccine was developed by Bharat Biotech International Limited (BBIL) in collaboration with Biotechnology Industry Research Assistance (BIRAC).

  • The intranasal COVID-19 vaccine is set to receive approval for a primary 2-dose schedule and as a heterologous booster dose.
  • The rollout of iNCOVACC is expected to begin in private hospitals that have placed advance orders.
  • An initial manufacturing capacity of several million doses per annum has been established and can be scaled up to a billion doses as required.
  • iNCOVACC is priced at 325 rupees per dose for large-volume procurement by state and central government.

Dr. Mandaviya stated that over 65 percent of vaccines supplied in the world are from India and that this marks a glorious tribute to the call for Atmanirbhar Bharat. The Union Health Minister also highlighted India’s vaccine manufacturing and innovation capabilities and its success in producing quality and affordable medicines.

हिंदी में पढ़े

Scroll to Top